ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2026, Vol 16, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Evolutionary Origin and Conserved Structural Building Blocks of Riboswitches and Ribosomal RNAs: Riboswitches as Probable Target Sites for Aminoglycosides Interaction

Elnaz Mehdizadeh Aghdam, Abolfazl Barzegar*, Mohammad Saeid Hejazi*

Adv Pharm Bull. 2014;4(3): 225-235. doi: 10.5681/apb.2014.033

PMCID: PMC3992957 PMID: 24754005 Scopus ID: 84983580755

Article

PDF

XML

Cited By:

Original Research

2. Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells

Hadi Karami, Behzad Baradaran*, Ali Esfahani, Masoud Sakhinia, Ebrahim Sakhinia*

Adv Pharm Bull. 2014;4(3): 243-248. doi: 10.5681/apb.2014.035

PMCID: PMC3992959 PMID: 24754007 Scopus ID: 84983573919

Article

PDF

XML

Cited By:

Editorial

3. Ranking Predatory Journals: Solve the Problem Instead of Removing It!

Mehdi Dadkhah*, Giorgio Bianciardi

Adv Pharm Bull. 2016;6(1): 1-4. doi: 10.15171/apb.2016.001

PMCID: PMC4845555 PMID: 27123411 Scopus ID: 84962449920

Article

PDF

XML

Cited By:

Research Article

4. Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468)

Behzad Mansoori, Ali Mohammadi, Samira Goldar, Dariush shanehbandi, Leila Mohammadnejad, Elham Baghbani, Tohid Kazemi, Saeed Kachalaki, Behzad Baradaran*

Adv Pharm Bull. 2016;6(2): 171-177. doi: 10.15171/apb.2016.024

PMCID: PMC4961974 PMID: 27478778 Scopus ID: 84980350575

Article

PDF

XML

Cited By:

Reviews

5. RNA Interference and its Role in Cancer Therapy

Behzad Mansoori, Siamak Sandoghchian Shotorbani, Behzad Baradaran*

Adv Pharm Bull. 2014;4(4): 313-321. doi: 10.5681/apb.2014.046

PMCID: PMC4137419 PMID: 25436185 Scopus ID: 84906273175

Article

PDF

XML

Cited By:

152

Research Article

6. Strategies for Improving siRNA-Induced Gene Silencing Efficiency

Fatemeh Safari*, Solmaz Rahmani Barouji, Ali Mohammad Tamaddon

Adv Pharm Bull. 2017;7(4): 603-609. doi: 10.15171/apb.2017.072

PMCID: PMC5788215 PMID: 29399550 Scopus ID: 85043385514

Article

PDF

XML

Cited By:

Review Article

7. Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells

Sara Aqmasheh, karim Shamsasanjan*, Parvin Akbarzadehlaleh, Davod Pashoutan Sarvar, Hamzeh Timari

Adv Pharm Bull. 2017;7(2): 165-177. doi: 10.15171/apb.2017.021

PMCID: PMC5527230 PMID: 28761818 Scopus ID: 85021389670

Article

PDF

XML

Cited By:

Research Article

8. The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery

Sanam Nami, Behzad Baradaran, Behzad Mansoori, Parivash Kordbacheh, Sasan Rezaie, Mehraban Falahati, Leila Mohamed Khosroshahi, Mahin Safara, Farideh Zaini*

Adv Pharm Bull. 2017;7(1): 53-59. doi: 10.15171/apb.2017.007

PMCID: PMC5426734 PMID: 28507937 Scopus ID: 85017558190

Article

PDF

XML

Cited By:

Original Research

9. Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

Mostafa Heidari Majd, Jaleh Barar*, Davoud Asgari, Hadi Valizadeh, Mohammad Reza Rashidi, Vala Kafil, Javid Shahbazi, Yadollah Omidi

Adv Pharm Bull. 2013;3(1): 189-195. doi: 10.5681/apb.2013.031

PMCID: PMC3846035 PMID: 24312834 Scopus ID: 84874982615

Article

PDF

XML

Cited By:

Review Article

10. The Different Mechanisms of Cancer Drug Resistance: A Brief Review

Behzad Mansoori, Ali Mohammadi, Sadaf Davudian, Solmaz Shirjang, Behzad Baradaran*

Adv Pharm Bull. 2017;7(3): 339-348. doi: 10.15171/apb.2017.041

PMCID: PMC5651054 PMID: 29071215 Scopus ID: 85030114747

Article

PDF

XML

Cited By:

651

451

1283

Research Article

11. Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells

Naime Majidi Zolbanin , Reza Jafari , Jafar Majidi , Fatemeh Atyabi , Mehdi Yousefi , Farhad Jadidi-Niaragh , Leili Aghebati-Maleki , Dariush Shanehbandi , Mohammad-Sadegh Soltani Zangbar, Alireza Mohajjel Nayebi

Adv Pharm Bull. 2018;8(3): 383-393. doi: 10.15171/apb.2018.045

PMCID: PMC6156474 PMID: 30276134 Scopus ID: 85052582866

Article

PDF

XML

Cited By:

Short Communication

12. The Increased RNase Activity of IRE1α in PBMCs from Patients with Rheumatoid Arthritis

Mahdieh Ahmadiany, Mahshid Alavi-Samani, Zahra Hashemi, Mohammad Amin Moosavi , Marveh Rahmati*

Adv Pharm Bull. 2019;9(3): 505-509. doi: 10.15171/apb.2019.060

PMCID: PMC6773928 PMID: 31592115 Scopus ID: 85070448366

Article

PDF

XML

Cited By:

Short Communication

13. Antiurolithiatic Activity of Gokhsuradi Churan, an Ayurvedic Formulation By In Vitro Method

Ashok Kumar Bagepalli Srinivasa*, Lakshman Kuruba, Saleemulla Khan, Gopi Setty Saran

Adv Pharm Bull. 2013;3(2): 477-479. doi: 10.5681/apb.2013.080

PMCID: PMC3848215 PMID: 24312883 Scopus ID: 84885712475

Article

PDF

XML

Cited By:

Original Research

14. Nucleostemin depletion induces post-G1 arrest apoptosis in chronic myelogenous leukemia K562 cells

Negin Gogani, Marveh Rahmati, Nosratollah Zarghami, Iraj Asvadi-Kermani, Mohammad Ali Hoseinpour-Feyzi, Mohammad Amin Moosavi*

Adv Pharm Bull. 2014;4(1): 55-60. doi: 10.5681/apb.2014.009

PMCID: PMC3885370 PMID: 24409410 Scopus ID: 84892465978

Article

PDF

XML

Cited By:

Research Article

15. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53

Saeed Noorolyai , Elham Baghbani , Leili Aghebati Maleki , Amir Baghbanzadeh Kojabad, Dariush Shanehbansdi, Vahid Khaze Shahgoli, Ahad Mokhtarzadeh , Behzad Baradaran*

Adv Pharm Bull. 2020;10(1): 130-134. doi: 10.15171/apb.2020.017

PMCID: PMC6983996 PMID: 32002372 Scopus ID: 85084315763

Article

PDF

Abstracting and Indexing

1. Evolutionary Origin and Conserved Structural Building Blocks of Riboswitches and Ribosomal RNAs: Riboswitches as Probable Target Sites for Aminoglycosides Interaction

2. Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells

3. Ranking Predatory Journals: Solve the Problem Instead of Removing It!

4. Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468)

5. RNA Interference and its Role in Cancer Therapy

6. Strategies for Improving siRNA-Induced Gene Silencing Efficiency

7. Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells

8. The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery

9. Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

10. The Different Mechanisms of Cancer Drug Resistance: A Brief Review

11. Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells

12. The Increased RNase Activity of IRE1α in PBMCs from Patients with Rheumatoid Arthritis

13. Antiurolithiatic Activity of Gokhsuradi Churan, an Ayurvedic Formulation By In Vitro Method

14. Nucleostemin depletion induces post-G1 arrest apoptosis in chronic myelogenous leukemia K562 cells

15. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53

16. Alpha7 Nicotinic Acetylcholine Receptor Mediates Nicotine-induced Apoptosis and Cell Cycle Arrest of Hepatocellular Carcinoma HepG2 Cells

17. Classification of Riboswitch Families Using Block Location-Based Feature Extraction (BLBFE) Method

18. Snail-1 Silencing by siRNA Inhibits Migration of TE-8 Esophageal Cancer Cells Through Downregulation of Metastasis-Related Genes

19. Transcriptome Changes in Colorectal Cancer Cells upon Treatment with Avicequinone B

20. Up-Regulation of Cell-Free MicroRNA-1 and MicroRNA-221-3p Levels in Patients with Myocardial Infarction Undergoing Coronary Angiography

21. Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities

22. Micromanaging Glucose Tolerance and Diabetes

23. Protective Role of trans-Chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451

24. siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells

25. miR‐146a‐5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway

26. microRNA‐193a‐5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9

27. Tailored Limonene-Based Nanosized Microemulsion: Formulation, Physicochemical Characterization and In Vivo Skin Irritation Assessment

28. Improving the Expression of Human Granulocyte Colony Stimulating Factor in Escherichia coli by Reducing the GC-content and Increasing mRNA Folding Free Energy at 5’-Terminal End

29. MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study

30. Detection and Management of Common Medication Errors inInternal Medicine Wards: Impact on Medication Costs and Patient Care

31. Chitosan and Its Structural Modifications for siRNA Delivery

32. Comparative Evaluation of Lipofectamine and Dendrimer for Transfection of Short RNA Into Human T47D and MCF-10A Cell Lines

33. MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?

34. mRNA as a Therapeutics: Understanding mRNA Vaccines

35. The Role of Estrogen in Brain MicroRNAs Regulation

36. The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro

37. A Toolkit for Detecting Fallacious Calls for Papers from Potential Predatory Journals

38. Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line

39. Unmasking Greenwashing: Mapping Hijacked Medicine Journals to the Sustainable Development Goals

40. MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations

41. Therapeutic Potential of Circular RNAs as Targets for Cancer Treatment

42. Silencing Calumenin Expression via Artificial MicroRNA, a Potential Breakthrough for Inhibiting Proliferation, Halting Migration, and Triggering Apoptosis in Breast Cancer Cells

43. GAS5 in Colorectal Cancer: A Multifaceted Long Non-Coding RNA in Tumor Suppression, Prognosis and Therapeutic Targeting

44. Continuous Uptake of MiR-181a-2 Mimetic Induces Constitutive Overexpression of Cellular MiR-181a-2 in MCF-7 Breast Cancer Cells: Links with Progression of Drug Resistance

45. Predatory Medical Journals in Patent Literature: A Hidden Threat

46. Diagnosis Unreliability of ChatGPT for Journal Evaluation

47. Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment

48. A Decade in Hijacked Journals: What Will be the Future Trend?

49. Unveiling the Hidden Menace: A Topic Modeling Analysis of Hijacked Medical Journals

50. The RNA-Binding Proteins Promote Resistance of Microglial Cells to Hypoxia

51. GAS2 Co-Expression Networks in Breast Cancer: Identification of Potential Biomarkers and Therapeutic Targets

52. Impact of Elateriospermum tapos Supplementation on Leptin and Hypothalamic Signaling in Female Offspring of High-Fat Diet-Induced Obese

53. Galangin’s Therapeutic Potential in Retinoblastoma: Inducing Apoptosis and Modulating RB Protein and Some MicroRNAs

54. Delivery Systems of mRNA Vaccines in the Treatment of Infectious Diseases: From Lipid Nanoparticles to Next-Generation Platforms

55. siRNA and mRNA-Based Preventive and Therapeutic Strategies for HPV-Induced Cervical Cancer

56. Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?